CB
BIO icon

Commerce Bank’s Bio-Rad Laboratories Class A BIO Stock Holding History

Commerce Bank’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-801
Closed -$263K – 1179
2024
Q4 		$263K Buy
801
+84
+12% +$28.5K ﹤0.01% 1063
2024
Q3 		$240K Buy
+717
New +$228K ﹤0.01% 1124
2024
Q2 		– Sell
-746
Closed -$258K – 1198
2024
Q1 		$258K Buy
746
+51
+7% +$16.8K ﹤0.01% 1074
2023
Q4 		$224K Sell
695
-55
-7% -$17.2K ﹤0.01% 1104
2023
Q3 		$269K Sell
750
-8
-1% -$3.09K ﹤0.01% 989
2023
Q2 		$287K Buy
758
+148
+24% +$60.2K ﹤0.01% 982
2023
Q1 		$292K Sell
610
-429
-41% -$201K ﹤0.01% 991
2022
Q4 		$437K Sell
1,039
-2
-0.2% -$807 ﹤0.01% 842
2022
Q3 		$435K Sell
1,041
-223
-18% -$111K ﹤0.01% 816
2022
Q2 		$625K Buy
1,264
+403
+47% +$210K 0.01% 685
2022
Q1 		$485K Sell
861
-60
-7% -$36.2K ﹤0.01% 843
2021
Q4 		$696K Sell
921
-16
-2% -$12K ﹤0.01% 732
2021
Q3 		$699K Buy
937
+252
+37% +$189K ﹤0.01% 718
2021
Q2 		$441K Buy
685
+21
+3% +$12.8K ﹤0.01% 877
2021
Q1 		$379K Sell
664
-114
-15% -$67.5K ﹤0.01% 901
2020
Q4 		$454K Sell
778
-83
-10% -$47.3K ﹤0.01% 809
2020
Q3 		$444K Buy
861
+178
+26% +$90.2K ﹤0.01% 723
2020
Q2 		$308K Sell
683
-843
-55% -$372K ﹤0.01% 832
2020
Q1 		$535K Buy
1,526
+516
+51% +$190K 0.01% 566
2019
Q4 		$374K Sell
1,010
-12
-1% -$4.23K ﹤0.01% 743
2019
Q3 		$340K Buy
1,022
+149
+17% +$48.6K ﹤0.01% 737
2019
Q2 		$273K Buy
873
+58
+7% +$17.4K ﹤0.01% 794
2019
Q1 		$249K Buy
+815
New +$220K ﹤0.01% 779

Other funds holding BIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Commerce Bank's BIO Position: Q1 2025 in Review

Commerce Bank sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2025, closing a stake of 801 shares — an estimated $263K sold.

Commerce Bank first reported a position in BIO in Q1 2019 and held it in 23 quarters. The position peaked at $699K in Q3 2021. 436 funds tracked by Wall St. Rank hold BIO as of Q1 2025.

  • Commerce Bank reported no remaining Bio-Rad Laboratories Class A position as of Q1 2025 after selling out during the quarter.
  • Commerce Bank sold 801 Bio-Rad Laboratories Class A shares in Q1 2025, an estimated $263K.
  • Commerce Bank first reported a position in Bio-Rad Laboratories Class A in Q1 2019 and held it in 23 quarters.
  • Commerce Bank's Bio-Rad Laboratories Class A position peaked at $699K in Q3 2021.
  • 436 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2025.

Based on Commerce Bank's 13F filing for Q1 2025, filed 8 May 2025.